Package 68788-8171-3

Brand: terazosin

Generic: terazosin
NDC Package

Package Facts

Identity

Package NDC 68788-8171-3
Digits Only 6878881713
Product NDC 68788-8171
Product ID 68788-8171_933b040f-e49e-4ff9-a6f2-1124b97bbe57
Description

30 CAPSULE in 1 BOTTLE (68788-8171-3)

Marketing

Marketing Status
Marketed Since 2022-04-25
Brand terazosin
Generic terazosin
Sample Package No

Linked Drug Pages (1)

terazosin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "933b040f-e49e-4ff9-a6f2-1124b97bbe57", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["a78f74ce-1c53-41ea-878e-13674db10a67"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68788-8171-3)", "package_ndc": "68788-8171-3", "marketing_start_date": "20220425"}], "brand_name": "terazosin", "product_id": "68788-8171_933b040f-e49e-4ff9-a6f2-1124b97bbe57", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "68788-8171", "generic_name": "terazosin", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075614", "marketing_category": "ANDA", "marketing_start_date": "20220425", "listing_expiration_date": "20261231"}